Drug Type Mesenchymal stem cell therapy |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Akan Biosciences LLCStartup |
Active Organization Akan Biosciences LLCStartup |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoarthritis, Knee | Phase 2 | US | Akan Biosciences LLCStartup | 12 Oct 2022 |
Autistic Disorder | Preclinical | US | Akan Biosciences LLCStartup | 12 Oct 2022 |
Osteoarthritis, Hip | Preclinical | US | Akan Biosciences LLCStartup | 12 Oct 2022 |
Shoulder arthritis | Preclinical | US | Akan Biosciences LLCStartup | 12 Oct 2022 |
Wounds and Injuries | Preclinical | US | Akan Biosciences LLCStartup | 12 Oct 2022 |